Fanny Bouquet

820 total citations
17 papers, 589 citations indexed

About

Fanny Bouquet is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fanny Bouquet has authored 17 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fanny Bouquet's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Fanny Bouquet is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Fanny Bouquet collaborates with scholars based in France, Switzerland and United States. Fanny Bouquet's co-authors include Bernard Salles, Catherine Muller, Rosemary J. Akhurst, Sandra Demaria, Karsten A. Pilones, Anupama Pal, Byron Hann, James S. Babb, Scott Lonning and J. Keith DeWyngaert and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Fanny Bouquet

16 papers receiving 585 citations

Peers

Countries citing papers authored by Fanny Bouquet

Since Specialization

Citations

This map shows the geographic impact of Fanny Bouquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Bouquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Bouquet more than expected).

Fields of papers citing papers by Fanny Bouquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Bouquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Bouquet. The network helps show where Fanny Bouquet may publish in the future.

Co-authorship network of co-authors of Fanny Bouquet

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Bouquet. A scholar is included among the top collaborators of Fanny Bouquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Bouquet. Fanny Bouquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Title	Journal	Authors	Indexed citations
1	Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI)	Clinical Cancer Research	Bernadett Szabados, Mariano Ponz‐Sarvisé et al.	3
2	252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience	Annals of Oncology	Chris Labaki, Ziad Bakouny et al.	3
3	Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience.	Journal of Clinical Oncology	Chris Labaki, Ziad Bakouny et al.	3
4	Clinico-genomic characterization of patients with metastatic urothelial carcinoma in real-world practice and development of a novel bladder immune prognostic index (BIPI).	Journal of Clinical Oncology	Bernadett Szabados, Mariano Ponz‐Sarvisé et al.	0
5	Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles	Scientific Reports	Anne Rodallec, Stéphane Robert et al.	15
6	Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma	Translational Oncology	Laëtitia Vercellino, Fanélie Jouenne et al.	13
7	Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)	Anti-Cancer Drugs	Anne Rodallec, Sarah Giacometti et al.	11
8	Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer	International Journal of Nanomedicine	Anne Rodallec, Jean Michel Brunel et al.	34
9	From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer	International Journal of Nanomedicine	Anne Rodallec, Sarah Giacometti et al.	26
10	Abstract 3709: Characterization, in vitro and in vivo efficacy studies of docetaxel trastuzumab stealth immunoliposome in human breast cancer models	Cancer Research	Anne Rodallec, Jean Michel Brunel et al.	2
11	Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib	Molecular Cancer Therapeutics	Judith Raimbourg, Marie‐Pierre Joalland et al.	17
12	Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib	Cancer Immunology Research	Marina Colombo, Meriem Messaoudene et al.	18
13	Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma	European Journal of Nuclear Medicine and Molecular Imaging	Aurélien Corroyer‐Dulmont, Elodie A. Pérès et al.	18
14	A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia	Journal of Cell Science	Fanny Bouquet, Marielle Ousset et al.	69
15	TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer CellsIn Vitroand Promotes Tumor Control by RadiationIn Vivo	Clinical Cancer Research	Fanny Bouquet, Anupama Pal et al.	202
16	Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease	Cell Cycle	Marielle Ousset, Fanny Bouquet et al.	45
17	The Loss of γH2AX Signal is a Marker of DNA Double Strand Breaks Repair Only at Low Levels of DNA Damage	Cell Cycle	Fanny Bouquet, Catherine Muller et al.	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact